Journal article
Early Predictors of Disability in Paediatric Multiple Sclerosis: Evidence from a Multi -National Registry
Sifat Sharmin, Charles Malpas, Izanne Roos, Ibrahima Diouf, Raed Alroughani, Serkan Ozakbas, Guillermo Izquierdo, Sara Eichau, Dana Horakova, Eva Kubala Havrdova, Francesco Patti, Murat Terzi, Cavit Boz, Bassem Yamout, Samia J Khoury, Marco Onofrj, Alessandra Lugaresi, Ayse Altintas, Alexandre Prat, Marc Girard Show all
Journal of Neurology, Neurosurgery and Psychiatry | BMJ Publishing Group | Published : 2022
Abstract
Background: Early recognition of markers of faster disability worsening in paediatric-onset multiple sclerosis (MS) is a key requisite of personalised therapy for children with MS at the earliest possible time. Objective: To identify early predictors of rapid disability accrual in patients with paediatric-onset MS. Methods: Using the global MSBase registry, we identified patients who were <18 years old at the onset of MS symptoms. The clinico-demographic characteristics examined as predictors of future MS Severity Score (MSSS) included sex, age at symptom onset, absence of disability at the initial assessment, maximum Expanded Disability Status Scale (EDSS) score, relapse frequency and p..
View full abstractRelated Projects (3)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
We thank the children and parents who contributed to the MSBase registry, the participating neurologists and the principal investigators for supporting this study. The list of MSBase Study Group contributors is provided in online supplemental table.This study was funded by the NHMRC Australia (grant 1129189 and fellowship 1140766). The MSBase Foundation is a not-for-profit organisation that receives support from Merck, Biogen, Novartis, Roche, Bayer Schering, Sanofi Genzyme and Teva Pharmaceutical Industries.